HomeCare March 4, 2021

DENVER —InnovAge Holding Corp. announced the pricing of its initial public offering of 16,666,667 shares of its common stock at a price to the public of $21.00 per share. The shares are expected to begin trading on the Nasdaq Global Select Market (Nasdaq) under the ticker symbol “INNV” on March 4, 2021, and the offering is expected to close on March 8, 2021, subject to customary closing conditions. In addition, InnovAge has granted the underwriters a 30-day option to purchase up to an additional 2,500,000 shares of common stock at the initial public offering price less underwriting discounts and commissions.

InnovAge helps manage the care of high-cost, dual-eligible seniors. The company’s mission is to enable seniors to age independently in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Post-Acute Care, Provider, Trends
Funding Flows to Value-Based Care, Defib Tech, Analytics, and More | StartUp Health Insights: Week of Apr 23, 2024
Evidence On Private Equity Suggests That Containing Costs And Improving Outcomes May Go Hand-In-Hand
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet
‘Investors Are Hungry To Find the Best’: It’s Feast or Famine in Digital Behavioral Health Investing
Avive scores $57M for portable cardiac arrest device

Share This Article